The 2023 SIUU Communication Draft Guidance (or “2023 Draft Guidance”) provides FDA’s interpretation of how unapproved uses of approved or cleared medical products can be communicated by firms in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback